Research Scientist, Cell Biology
Eureka Therapeutics, Inc.
Location: Emeryville, CA 94608
Position type: Full-time
Required education: Ph.D.
Area(s) of expertise desired: Cell Biology, Immunology
Description:
The Research Scientist, Cell Biology will join an experienced in-house team in the discovery and
development of fully-human therapeutic antibody drugs for innovative cancer immunotherapies.
The candidate will actively participate in scientific discussions and contribute to experimental designs related
to his/her own scientific projects. He/she will perform hands-on bench work including, but not limited to,
mammalian cell culture, virus transduction and production, phenotypic characterization of human T cells, T
cell activation/cytotoxic killing assay, FACS, immunofluorescence, ELISA, ELISPOT, cytokine and chemokine
detection. He/she will develop multidisciplinary knowledge and expertise in translating the latest biomedical
discoveries in breakthrough cancer immunotherapies.
Qualifications:
The ideal candidate will have a comprehensive understanding of T cell immunology combined with practical
and technical experience in cell biology and oncology. He/she is a hard-working and motivated team player
with a can-do attitude.
Requirements
Ph.D. in Cell Biology, Oncology, Immunology, or related field with post-doctoral or industrial
experiences. Previous experience in antibody drug discovery is preferred.
Proven track record of success in scientific creativity and independent thinking, including a strong
publication/patent record.
Excellent communication skills, including written reports/scientific publications, and presentations to
the senior management team and external stakeholders.
Strong analytical and problem-solving skills.
To Apply:
Please send resume and cover letter to [email protected].
About Eureka Therapeutics, Inc:
Eureka Therapeutics is a privately-held biotechnology company headquartered in Emeryville, California,
focused on developing first-in-class T cell-based immunotherapy for hematological malignancies and solid
tumors. Eureka is a leader in the discovery of novel antibody immunotherapies. Our core technology
platforms center around the discovery and engineering of fully-human antibodies against intracellular
oncogene targets via the MHCI complex. We have built an early stage pipeline of innovative drugs, with the
most advanced candidates at preclinical stage. In addition to our internal drug discovery programs, Eureka
has ongoing partnerships with Memorial Sloan Kettering Cancer Center, City of Hope National Medical Center,
and Boehringer Ingelheim. For more information about Eureka Therapeutics, please visit:
www.eurekainc.com.
Eureka Therapeutics is an equal opportunity employer and does not discriminate against otherwise qualified
applicants on the basis of race, religion, color, sex, age, ancestry, national origin, marital status, veteran status,
medical conditions, handicap, physical or mental disability, sexual orientation, or any other status protected by law.